Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Post by Gamestorm7on Nov 01, 2018 1:24pm
118 Views
Post# 28909111

Keep Holding That Breath

Keep Holding That BreathMany investors in iCo are under water.  I believe someone previously indicated that when the company's share float traded over 2 - 3 times, the average share cost was in that $0.15 - $0.16 range.  I myself am holding a loss near 50%.  I will not be selling anytime soon.  There are too many indications that there is more positive than negative coming to this company.  If you look at the time line of events, 5 months from the inital breakout and spike to where we are at now isn't that long.  The company is addressing the funding issue for continued operations as mentioned in the last NR.  In my mind, this is addressed and we will find out a resolution this quarter.  Other people have indicated no news until March or whatever; however, I believe we get news regarding this before the new year.  Anyway, I am going to continue to hold my breath and hope fellow investors like myself can as well.  Patience will pay off on this play, I truly believe that.  My opinions only.  GLTA
<< Previous
Bullboard Posts
Next >>